47.73.Z - Retail sale of pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,2 | 1,5 | 1,5 | -0,3 |
Gross profit (loss) | 1,3 | 1,3 | 1,4 | 7,5 |
EBITDA | 1,4 | 1,4 | 1,5 | 10,1 |
Short time liabilities | 0,3 | 0,4 | 0,4 | 17,8 |
Other operating costs | 0,2 | 0,2 | 0,2 | -4,5 |
Equity capital | 2,8 | 2,6 | 3,1 | 16,7 |
Operating profit (EBIT) | 1,3 | 1,3 | 1,4 | 7,5 |
Assets | 3,3 | 3,2 | 3,7 | 15,8 |
Net profit (loss) | 1,3 | 1,3 | 1,4 | 7,5 |
Cash | 1,2 | 0,5 | 0,8 | 53,4 |
Liabilities and provisions for liabilities | 0,6 | 0,6 | 0,6 | 11,8 |
Net income from sale | 14,8 | 16,5 | 18 | 9,2 |
Working assets | 3,3 | 3,2 | 3,4 | 7,3 |
Other income costs | 0,3 | 0 | 0,1 | 230,1 |
Depreciation | 0,1 | 0 | 0,1 | 118,3 |
% | % | % | p.p. | |
Profitability of capital | 48,3 | 49,9 | 46 | -3,9 |
Equity capital to total assets | 83,3 | 82,6 | 83,2 | 0,6 |
Gross profit margin | 9,1 | 8 | 7,9 | -0,1 |
EBITDA Margin | 9,5 | 8,2 | 8,3 | 0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 8 | 8 | 9 | 1 |
Current financial liquidity indicator | 10.208913803100586 | 8.7128267288208 | 7.937503337860107 | -0,8 |
Net dept to EBITDA | -0.6807141900062561 | -0.3496033847332001 | -0.5569450855255127 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane